Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Chagee Holdings (NASDAQ:CHA) Falls 7% Today After Valuation Analysis Flags Stock as Overvalued

• A valuation analysis flagged the stock as overvalued near its estimated fair value of approximately $11.98.

Vinay Lochav | 02 July 2026

IP Strategy Holdings (NASDAQ:IPST): Why Is This Penny Stock Up 6% Today?

• The company was formerly known as Heritage Distilling Holding Company.

Vinay Lochav | 02 July 2026

Procter & Gamble (NYSE:PG) Advances 2% Today as Investors Rotate Into Defensive Names

• The company reported a Q4 earnings per share beat of $1.59 versus $1.56 estimated.

Vinay Lochav | 02 July 2026

National Beverage (NASDAQ:FIZZ) Jumps 11% Today Despite Earnings Miss, on Special $3.25 Dividend

• The board declared a special cash dividend of $3.25 per share.

Vinay Lochav | 02 July 2026

Moody's Corporation (NYSE:MCO) Climbs 3% Today on Index Inclusion and AI Strategy Optimism

• MCO shares rose 3.46% today to $484.58, outperforming both the broader financial sector and the S&P 500.

Vinay Lochav | 02 July 2026

Anheuser-Busch InBev (NYSE:BUD) Recovers Modestly Today Following Sector-Wide Weakness

• Constellation Brands' Q1 earnings miss weighed on the broader brewer sector earlier this week.

Vinay Lochav | 02 July 2026

Philip Morris International (NYSE:PM) Gains Today on First-Ever FDA Reduced-Risk Authorization for ZYN Nicotine Pouches

• PM shares rose 1.35% today to $180.09, outperforming the broader market and consumer staples sector.

Vinay Lochav | 02 July 2026

YD Bio (NASDAQ:YDES) Falls 13% Today Despite Lab Footprint Expansion

• The company's affiliate obtained new clinical laboratory licenses in Rhode Island and Pennsylvania.

Vinay Lochav | 02 July 2026

Amgen (NASDAQ:AMGN) Climbs 3% Today After Court Blocks Colorado Price Cap

• A federal judge granted a preliminary injunction blocking Colorado's price cap on Amgen's rheumatoid arthritis drug Enbrel.

Vinay Lochav | 02 July 2026

Elicio Therapeutics (NASDAQ:ELTX) Falls 35% Today on Dilutive Offering

• The company priced a $15 million registered direct equity offering to fund cancer program development.

Vinay Lochav | 02 July 2026
Support

Hi! How can we help you today?

Loading…